PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function

Journal of Neuroscience

Volumn 17, Issue 9, 1997, Pages 3168-3177

  Black, Kevin J ^a,b   Gado, Mokhtar H ^a   Perlmutter, Joel S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Campus Box 8134 ^*  (United States)

Author keywords

baboon; dopamine D2 receptor; globus pallidus; pharmacological activation; positron emission tomography; U91356a

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOMPERIDONE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; ETICLOPRIDE; KETANSERIN; U 91356A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BRAIN BLOOD FLOW; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DEPENDENCE; DYSTONIA; FEMALE; GILLES DE LA TOURETTE SYNDROME; GLOBUS PALLIDUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE PROJECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030910350     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-09-03168.1997     Document Type: Article

References (20)

1. Åkeson J, Björkman S, Messeter K, Rosen I, Helfer M (1993) Cerebral pharmacodynamics of anaesthetic and subanaesthetic doses of ketamine in the normoventilated pig. Acta Anaesthesiol Scand 37:211-218.
2. Azuma H, Miyazawa T, Mizokawa T, Magota A, Hara K (1988) Stimulatory effects of lisuride on local cerebral blood flow and local cerebral glucose utilization in rats. Nippon Yakurigaku Zasshi 91:341-349.
3. Bacopoulos. NG, Redmond DE, Roth RH (1979) Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine. J Neurochem 32:1215-1218.
4. Beck T, Vogg P, Krieglstein J (1986) Effects of the indirect dopaminomimetic diethylpemoline on local cerebral glucose utilization and local cerebral blood flow in the conscious rat. Eur J Pharmacol 125:437-447.
5. Beck T, Vogg P, Krieglstein J (1988) Uncoupling of cerebral blood flow and glucose utilization by dihydroergocristine in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol 338:82-87.
6. Bédard PJ, Gomez Mancilla B, Blanchette P, Gagnon C, Di Paolo T (1992) Levodopa-induced dyskinesia: facts and fancy. What does the MPTP monkey model tell us? Can J Neurol Sci 19:134-137.
7. Berntman L, Carlsson C, Hagerdal M, Siesjo BK (1976) Excessive increase in oxygen uptake and blood flow in the brain during amine intoxication. Acta Physiol Scand 97:264-266.
8. Berntman L, Carlsson C, Hagerdal M, Siesjo BK (1978) Circulatory and metabolic effects in the brain induced by amphetamine sulphate. Acta Physiol Scand 102:310-323.
9. Björkman S, Åkeson J, Nilsson F, Messeter K, Roth B (1992) Ketamine and midazolam decrease cerebral blood flow and consequently their own rate of transport to the brain: an application of mass balance pharmacokinetics with a changing regional blood flow. J Pharmacokinet Biopharm 20:637-652.
10. Black KJ, Videen TO, Perlmutter JS (1996a) A metric for testing the accuracy of cross-modality image registration: validation and application. J Comp Assist Tomogr 1996:20:855-861.
11. Black KJ, Videen TO, Perlmutter JS (1996b) Regional effects of a D3-preferring agonist on cerebral blood flow. Soc Neurosci Abstr 22(Part 1):498.
12. 1 agonist. J Neuropsychiatry Clin Neurosci 9:132.
13. Bloch B, LeMoine C (1994) Neostriatal dopamine receptors. Trends Neurosci 17:3-4.
14. Breece OR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA (1987) 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J Pharmacol Exp Ther 240:167-176.
15. Cavazzuti M, Porro CA, Biral GP, Benassi C, Barbieri GC (1987) Ketamine effects on local cerebral blood flow and metabolism in the rat. J Cereb Blood Flow Metab 7:806-811.
16. Celsis P, Rascol O, Demonet JF, Agniel A, Montastruc JL, Marc-Vergnes JP, Rascol A (1988) Effet de la bromocriptine sur le debit sanguin cerebral dans la maladie de Parkinson. Rev Neurol (Paris) 144:367-371.
17. Cleghorn JM, Szechtman H, Garnett ES, Nahmias C, Brown GM, Kaplan RD, Szechtman B, Franco S (1991) Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients. Psychiatry Res 40:135-153.
18. Woods RP, Mazziotta JC, Cherry SR (1993) MRI-PET registration with automated algorithm. J Comp Assist Tomogr 14:536-546.
19. Yaster M, Koehler RC, Traystman RJ (1994) Interaction of fentanyl and nitrous oxide on peripheral and cerebral hemodynamics in newborn lambs. Anesthesiology 80:364-371.
20. Young AB, Penney JB (1993) Biochemical and functional organization of the basal ganglia. In: Parkinson's disease and movement disorders, 2nd Ed (Jankovic J, Tolosa E, eds), pp 1-11. Baltimore: Williams & Wilkins.